Charles T. Van Buren

Medicine · Health Sciences

42h-index5.8kcitations120works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Transplantation Outcomes and Treatments(59), Organ Transplantation Techniques and Outcomes(27), Organ Donation and Transplantation(18), Transplantation: Methods and Outcomes(17), Pharmacological Effects and Toxicity Studies(16)

Publications120 total

Systemic Racism Harms Black Americans’ Access to Kidney Transplantation and Full Participation in Organ Donation
Progress in Transplantation·2021· 5 cited
Clinical Results of Ciclosporin-Prednisone Therapy in Renal Transplantation
Contributions to nephrology·2015
94-P C1q positive antibodies in patients with donor specific HLA antibodies and post transplant rejection
Human Immunology·2011
63-P The relevance of pre-transplant soluble HLA-G levels and/or donor specific HLA antibodies on renal allograft survival
Human Immunology·2011
Rapid estimation of whole blood everolimus concentrations using architect sirolimus immunoassay and mathematical equations: comparison with everolimus values determined by liquid chromatography/mass spectrometry
Journal of Clinical Laboratory Analysis·2011· 17 cited
26-P: Frequency of Donor Specific HLA (DSA) Antibody in a Transplant Population and Their Clinical Impact
Human Immunology·2010
27-P: Transplantation of Donor Specific HLA Antibody Positive, FCXM Negative Renal Allograft Recipients
Human Immunology·2010
Comparing an Early Corticosteroid/Late Calcineurin-Free Immunosuppression Protocol to a Sirolimus-, Cyclosporine A-, and Prednisone-Based Regimen for Pancreas-Kidney Transplantation
Transplantation·2010· 23 cited
Thrombelastography in a Patient with Prolonged Partial Thromboplastin Time Undergoing a Kidney Transplant
Anesthesia & Analgesia·2009
49-OR: Consequences of allocating deceased donor organs based on recipient antibody specificities
Human Immunology·2008· 1 cited
55-OR: Antibody amount, does not predict crossmatch
Human Immunology·2008
Risk factors for impaired wound healing in sirolimus‐treated renal transplant recipients
Clinical Transplantation·2007· 115 cited
8-P
Human Immunology·2006
Long‐term outcomes of single paediatric vs. ideal adult renal allograft transplants in adult recipients
Clinical Transplantation·2006· 14 cited
Pancreas Transplantation Utilizing Thymoglobulin, Sirolimus, and Cyclosporine
Transplantation·2006· 15 cited
Low Incidence of Malignancy among Sirolimus/Cyclosporine-Treated Renal Transplant Recipients
Transplantation·2005· 133 cited
Phase I and Phase II Safety and Efficacy Trial of Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302) for the Prevention of Acute Allograft Rejection
Transplantation·2004· 31 cited
The Selective Use of Basiliximab Versus Thymoglobulin in Combination with Sirolimus for Cadaveric Renal Transplant Recipients at Low Risk Versus High Risk for Delayed Graft Function
Transplantation·2004· 57 cited
Increasing Organ Recovery from Level I Trauma Centers: The In-House Coordinator Intervention
Progress in Transplantation·2004· 31 cited
LETTERS TO THE EDITOR
American Journal of Critical Care·2004· 3 cited
page 1 of 6Next →

Frequent Co-authors

Barry D. Kahan(30), Ronald H. Kerman(10), Stephen M. Katz(9), Richard M. Lewis(9), Stuart M. Flechner(9), Marc I. Lorber(8), Frederick B. Rudolph(8), Linda Schoenberg(6), Anil D. Kulkarni(6), RONALD H. KERMAN(5), Maria Welsh(4), Richard J. Knight(4), William C. Fanslow(4), Barry D. Kahan(4), Debbie Golden(3), O.H. Frazier(3), Jeanette M. Podbielski(2), Lynne P. Rutzky(2), Diana L. Urbauer(2), Stanley J. Dudrick(2)